DNA Script: Funding, Investors & Team (Aug 2026)
DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
DNA Script has raised $365M across 2 funding rounds on record, the most recent a Series C of $200M announced in Jan 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
DNA Script Company Profile and Key Stats
Latest funding round on record: Jan 2022.
DNA Script Funding Rounds
DNA Script raised $165M in a Series C announced in Oct 2021.
3 months later, a Series C of $200M was announced in Jan 2022.
DNA Script Founders and Leadership Team
No contact details are on record for this team yet.
DNA Script Funding Compared to Other Biotechnology Startups
DNA Script's latest round of $200M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like DNA Script in Biotechnology and Le Kremlin-bicêtre
Companies Similar to DNA Script
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
DNA Script Funding FAQs
What does DNA Script do?
DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
How much funding has DNA Script raised?
DNA Script has raised $365M across 2 rounds on record. The most recent is a Series C of $200M announced in Jan 2022.
When did DNA Script last raise funding?
DNA Script's most recent funding round on record is a Series C of $200M, announced in Jan 2022.
Who is the CEO of DNA Script?
Thomas Ybert is listed as CEO at DNA Script.
Where is DNA Script headquartered?
DNA Script is based in Le Kremlin-bicêtre, Ile-De-France, France.
How many employees does DNA Script have?
DNA Script is in the 101-250 employee band.
How does DNA Script's funding compare to other Biotechnology startups?
DNA Script's latest round of $200M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's DNA Script Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for DNA Script is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.